Grapefruit juice-drug interactions: Not just pulp fiction

Cardiovascular Reviews and Reports

Volumn 22, Issue 1, 2001, Pages 11-12

  Clifton, G D ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMLODIPINE; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ASTEMIZOLE; ATORVASTATIN; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CISAPRIDE; CYCLOSPORIN; CYTOCHROME P450 3A4; DIAZEPAM; FELODIPINE; FUROCOUMARIN; GLYCOPROTEIN P; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MEVINOLIN; MIDAZOLAM; NIFEDIPINE; NISOLDIPINE; NITRENDIPINE; SAQUINAVIR; SIMVASTATIN; TRIAZOLAM; VERAPAMIL;

DRUG ABSORPTION; DRUG SAFETY; EDITORIAL; FIRST PASS EFFECT; FOOD DRUG INTERACTION; FRUIT JUICE; GRAPEFRUIT JUICE;

EID: 0035096877     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Drug interactions with grapefruit juice: Extent, probable mechanism and clinical relevance
2. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A4 activity
3. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents: Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins
4. Grapefruit juice activates P-glycoprotein-mediated drug transport
5. The presently known distribution of furocoumarins (psoralens) in plants